- 24 September 2026
Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity
CU-MEDi encourages students to explore medicine through hands-on research and innovation, supported by experienced faculty and mentors throughout the process. From developing research questions and conducting studies to analyzing and presenting their findings, students can pursue diverse fields including Clinical Research, Basic Research, Medical Education, Innovation, and Data Science. These experiences turn curiosity into meaningful knowledge and new possibilities for the future of healthcare.
Latest CU-MEDi student research published in international journals, highlighting their growing contributions to the global medical community.
It builds an evidence-based mindset and encourages new ideas that can contribute to the future of healthcare.
Research projects led by faculty and medical experts, giving students opportunities to learn from and engage in real-world research across diverse fields of medicine.
Name | Publishsed article |
|---|---|
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Ponphisudti Tangsirisatian ,
Thitipat Jungteerapanich
and Pakteema Tongchairawewa | Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury
but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Name | Publishsed article |
|---|---|
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Ponphisudti Tangsirisatian ,
Thitipat Jungteerapanich
and Pakteema Tongchairawewa | Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury
but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Name | Publishsed article |
|---|---|
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Ponphisudti Tangsirisatian ,
Thitipat Jungteerapanich
and Pakteema Tongchairawewa | Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury
but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Name | Publishsed article |
|---|---|
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Ponphisudti Tangsirisatian ,
Thitipat Jungteerapanich
and Pakteema Tongchairawewa | Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury
but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Nont Oudomying | Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous
Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and
Rheumatoid Arthritis: A Prospective Cohort Study. |
Darlene Ariyaskul
and Kittipat Kulkraisri | Physician- and patient-reported barriers to hepatocellular carcinoma surveillance:
A nationwide survey. |
Chitchanok Cherdchoochart
and Tinn Hongboontry | Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after
Successful Treatment with Direct-Acting Antivirals. |
Discover research expertise across CU-MEDi, covering clinical and basic sciences, innovation, and data science, while helping students connect with fields and mentors that match their interests.
An integrated research experience where CU-MEDi students develop their own biomedical research projects under faculty mentorship, from exploring a research question to analyzing and presenting their findings.
Center of Excellence in Clinical Virology, |Department of Pediatrics, Faculty of Medicine, Chulalongkorn University
Director of Comprehensive Stroke centre, King Chulalongkorn Memorial Hospital
Immunology Unit, Department of Microbiology, Faculty of Medicine
Center of Excellence in Clinical Virology, |Department of Pediatrics, Faculty of Medicine, Chulalongkorn University
Division of Research Affairs, Faculty of Medicine, Chulalongkorn University
Department of Preventive and Social Medicine, Faculty of Medicine
Faculty of Medicine, Chulalongkorn University
Department of Pharmacology, Faculty of Medicine, Chulalongkorn University
Division of Gastroenterology, Department of Medicine, King Chulalongkorn Memorial Hospital
Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University
Research interest :
• Hepatology
• Virology
• Molecular biology
• Epidemiology
• Emerging infectious diseas
biography :
Prof. Poovorawan is currently the Director of the Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University. He obtained the MD in 1974 from Chulalongkorn University and his specialization in pediatrics in 1978 from Chulalongkorn Hospital. In 1984, he became a Research Fellow in Paediatric Hepatology at King’s College Hospital Medical School, London.
He is widely noted for his research in the fields of pediatric hepatology, viral hepatitis and virology, and is regarded as a subject expert on clinical virology both nationally and internationally. He has authored more than 480 publications and received numerous awards for his contributions to his fields of research.
Director of Comprehensive Stroke centre, King Chulalongkorn Memorial Hospital
Research interest :
biography :
Prof. Suwanwela pioneered the ‘Stroke Fast Track’ program and the use of thrombolysis as well as establishment of stroke unit in Thailand. She also had a leading role in the development of telestroke network in Bangkok for acute stroke management. Her research mainly focused on acute stroke care and stroke care system in Thailand. Recently, she is the principle investigator of a large-scale population based study of atrial fibrillation in Thailand. She is also interested in innovation and technology where she received grants for development of stroke homecare robot and AI for stroke subtype prediction with the Faculty of Engineering, Chulalongkorn University.
Immunology Unit, Department of Microbiology, Faculty of Medicine
Research interest :
biography :
Post doctoral fellowship at NIH, USA for 5 years with 15 publication, including “Nature medicine”. Currently, 10 years in Chulalongkorn with 127 publications on “pubmed” and 20 publications per year for 3 years in a row. Our teams consist of nearly 15 persons with several laboratory techniques (Flow cytometry, Con focal microscopy, Seahorse cell energy analysis, microbiome analysis, etc.). Our ultimate goal is to translate the knowledge from basic science to the bedside clinical practice.
Biomedical Engineering Research Center and Metallurgical Engineering Department
Research interest :
biography :
Dr. Boonrat is an Associate Professor of Metallurgical Engineering at Chulalongkorn University. Dr. Boonrat held numerous advisory positions and executive positions such as: Committee Boards of the Faculty of Engineering, Chulalongkorn University, Director of Biomedical Engineering Research Center, Director of Chulalongkorn University Technology Center (UTC) MedTech division, Assistant Dean in Research, and Deputy Head of Department. He also advises various companies in the electronic, automotive, biomedical and jewelry industries. He has completed more than 30 research projects with industrial partners such as Western Digital, Pandora, Toyota, Mattel, Thaioil, IRPC, PTT, etc. He has received numerous awards including Thailand Young Metallurgist award (2013) and Thailand Young Technologist award from Princess Mahachakkri Sirindhorn (2012). Other accolades included Research Awards (2014, 2015), and Innovation Award (2007) from the Santa Fe Symposium for jewelry manufacturing technology. He has pioneered the 3D printing of biomedical titanium for orthopedic, plastic surgery and neuro-surgery applications. As the devices are fully customized patient-specific, the outcomes of 370+ clinical cases have shown this technology as a promising pathway to make impacts. The TFDA approval and commercialization of research gave birth to Meticuly, a spin-off company that focuses on the platform to create on-demand devices for leading medical professors from medical schools in Thailand and South East Asia. Conformed with Thai FDA and EN ISO13485, many products are currently in commercial stage helping patients in Thailand. As of 2020, several products are now submitted for USFDA 510(k). Working closely with surgeons in the fields of orthopedic, neuro surgery and plastic surgery, fully anatomical devices may restore full range of motions and expedited recovery. The drop-in solution allows for minimally-invasive incision and short surgical theater time. Meticuly recently received the following awards: First Place of the Digital Venture Accelerator batch 1 (2017), and First Place at the 5th Seedstars Global Summit (2018)’s pitch corner.
Department of Biochemistry
Research interest :
biography :
I’m interested in cell replacement and gene therapy for diseases related to the gastrointestinal system (gut, liver and pancreas). My previous work has engineered the gastric tissue as a renewable source for insulin production. My current work includes culture of adult stem cells from human gastrointestinal tract as a resource for production of new insulin-producing cells. In addition, I’m working on identifying therapeutic targets for treatment of liver fibrosis.
Division of Research Affairs, Faculty of Medicine, Chulalongkorn University
Research interest :
biography :
David Michael Payne received his undergraduate and doctoral degrees from the University of North Texas (B.S., Biology & Biochemistry; Ph.D., Molecular Biology & Biochemistry). He then completed five years of postdoctoral training at the Cancer Center, University of Virginia (UVA) School of Medicine. As a senior postdoc/assistant professor at UVA, Michael led the research team that discovered the identity of pp42 as MAP kinase and the mechanism for its regulated activation in mammalian signal transduction. He also led another research team that discovered a mechanism for malignant transformation of cells by the src-oncogene tyrosine kinase, involving novel “unscheduled” phosphorylation and activation of growth factor receptors (i.e., activation of receptor signaling in the absence of growth factor binding to receptors). During his career in the USA, Michael was a faculty member at four major universities plus the National Institutes of Health. He established a record of excellence in teaching and mentoring students, competed successfully at the national level for grant funding (National Science Foundation, National Institutes of Health and American Cancer Society), and published consistently in the top 10% of peer-reviewed journals in molecular/cell biology and biochemistry. He has been an international faculty member here at MDCU since 2015 (Feb), originally helping the director (Dr. Trairak Pisitkun) of the new CU Center of Excellence in Systems Biology to develop and lead that state-of-the-art biotechnology research facility (2015–2018). Since then, Michael has been leading an international collaboration in a translational research project to develop a ‘Next-Gen’ immunotherapy for treatment of snakebite envenoming (which creates more than 2 million victims annually, resulting in more than 400,000 disabilities and 100,000 deaths every year).
Department of Preventive and Social Medicine, Faculty of Medicine
Research interest :
biography :
Assoc. Prof. Dr. Krit Pongpirul is a health systems researcher, preventive, general, and emergency medicine clinician, as well as academic strategist. His expertise in Thai public and private health care sectors at organizational, national, and international levels has enabled him to explore both sickness and wellness aspects of human health. Following his report of the first Covid-19 case outside China in the New England Journal of Medicine, several works on the medical service, locally developed Covid-19 test kits, and vaccines as well as the involvement of the non-healthcare individuals such as Village Health Volunteers and flight attendants have been published in reputable peer-reviewed journals. His project proposal on wastewater-based bacterial, fungal, and viral microbiomes for Covid-19 received the Henry Boulard Public Health Award 2021. Also, his computer programming background also enables him to apply AI and Big Data in several national projects on communicable and non-communicable diseases including mass tuberculosis screening (DAC4TB)—that won Outstanding ICT Innovation Award at Asia Pacific HIMMS-Elsevier Digital Healthcare Awards 2019–as well as the ongoing nationwide skin cancer screening (DermDD), chronic kidney disease prevention and practice program (CP3), and AI-based personalized probiotics platform (AIP3).
Faculty of Medicine, Chulalongkorn University
Research interest :
biography :
Solaphat Hemrungrojn, MD Associated Professor Director of center of technology for cognitive care in elderly ( CU-Nectec) Director of cognitive fitness center , King Chulalongkorn Memorial Hospital Research interests – AI in neuroscience , Alzheimer’s center , Neuropsychological Assessment Short Bio Associated Professor Solaphat pioneered the cognitive fitness program for elderly to provide the elderly with ways to prevent dementia. She is director of cognitive fitness center , real lab for innovative work that can actually be brought into service. She also had a leading role in the development of neuropsychological assessment comprehensive system in Thailand. She is also interested in innovation such as brain computer interface training , AI for detect depression , Smart walker for dementia patient. She is member of executive board committee of UTC ( University technology center)of Chulalongkorn University.
King Chulalongkorn Memorial Hospital
Research interest :
biography :
Assoc. Prof Srimahachota interested in STEMI intervention and first established fast track system in Chulalongkorn Hospital and in Thailand since 1999. He had many publications in this field including Thai ACS registry. He was also one of the committee to establish Thai ACS guideline in 2020. He is also interested in structural heart intervention and one of the team in development of new the devices such as device closure in ASD/PDA/VSD, Hydra valve for TAVI and Omega LAA occluder device.
Department of Biochemistry
Research interest :
biography :
CB’s LAB is focusing on oxidative stress and epigenetic alteration in urolithiasis and cancer development. Cancers of our interest are bladder cancer and hepatocellular carcinoma. We have a strong intention to build innovative diagnostic and therapeutic products from our research findings. We seek people who think innovatively and have entrepreneurial mindset to join our journey.
Department of Pharmacology, Faculty of Medicine, Chulalongkorn University
Research interest :
biography :
Noppadol Wacharachaisurapol, BSc (Pharm), MD, is a lecturer at the Department of Pharmacology. He is also a researcher at the clinical pharmacokinetics and pharmacogenomics research unit. His research field includes pediatric infectious diseases especially MDROs treatment, antimicrobial pharmacokinetics, and antimicrobial stewardship.
Division of Gastroenterology, Department of Medicine, King Chulalongkorn Memorial Hospital
Research interest :
biography :
Dr. Mekaroonkamol is specialized in Gastroenterology and Advanced Endoscopy. His scholarly clinical endeavor centers on the innovative diagnostic and therapeutic endoscopic modalities for numerous digestive diseases, particularly on acute pancreatitis, obesity medicine, and gastric per-oral endoscopic pyloromyotomy (GPOEM), a novel endoscopic procedure to treat gastroparesis. He has published in many leading tier 1 journals in the field. His ongoing randomized controlled trials include studies on novel therapies for severe pancreatitis, preventive measures to reduce post-ERCP pancreatitis, and peroral endoscopic myotomy for achalasia. Conceptualizing project will focus on AI in Gastroenterology, Medical education on simulator-based endoscopy training, and bariatric endoscopy.
Have you ever imagined being your own personal doctor and managing your own health sitting in front of a TV at home? Testing that once seemed risky out of the hands of medical professionals is now more than ever a touchable reality. The advancement of handheld technology has brought an explosion of personal health gadgets such as smart watches that can monitor heart rate, blood pressure, breathing, and calories burned. High-speed internet advances have allowed for the efficient use of mobile phone applications, online consultant services, telemedicine, and even AI therapists. Some laboratory tests can even be ordered from home at the click of the button, with tool kits delivered and results available quickly online.
Future prospects of healthcare are moving from being doctor-centered to the patient viewpoint. Disease treatments will also expand to lifestyle remedies and coaching and extend out from visits to the hospital to a 24/7 online service. We might see more data doctors, where personal information of patients is streamed through an online platform and managed by professionals behind screens in ‘Care Hubs.’ After analysis of the person’s health data, they can provide individualized consult to each person, and recommend fitness programs that utilize entertainment and games to increase compliance. Personal devices will have bio-sensors to detect critical vital signs like irregular heartbeats and will be able to immediately send alerts to their doctors for any signs of life threatening conditions. Healthcare will be accessible where ever as internet connectivity becomes more and more ubiquitous.